The Kansas Bioscience Authority will commit $50 million to venture capital for Kansas-based bioscience companies, the agency said today.
"Capital is the lifeblood of bioscience companies," KBA CEO Tom Thornton said in a news release.
He said those companies are suffering "for a lack of early stage capital."
The money will be invested in eight private venture capital funds "with a substantial presence in the state" and will be required to raise an additional $25 million in order to distribute the KBA funds.
Sign Up and Save
Get six months of free digital access to The Wichita Eagle
Read more on this story in Friday's Eagle and at Kansas.com.